Market Watch Highlights: Fractyl Health Inc (GUTS) Ends on an Upturn Note at 1.92

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Fractyl Health Inc’s stock clocked out at $1.92, up 1.05% from its previous closing price of $1.90. In other words, the price has increased by $1.05 from its previous closing price. On the day, 0.13 million shares were traded. GUTS stock price reached its highest trading level at $1.94 during the session, while it also had its lowest trading level at $1.85.

Ratios:

To gain a deeper understanding of GUTS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.57 and its Current Ratio is at 5.58. In the meantime, Its Debt-to-Equity ratio is 1.25 whereas as Long-Term Debt/Eq ratio is at 1.15.

On February 27, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $18.

On February 27, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $26.BofA Securities initiated its Buy rating on February 27, 2024, with a $26 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 11 ’24 when Rajagopalan Harith sold 96,517 shares for $2.47 per share. The transaction valued at 238,358 led to the insider holds 491,329 shares of the business.

Caplan Jay David sold 64,197 shares of GUTS for $158,541 on Nov 11 ’24. The President, Chief Product Off. now owns 153,544 shares after completing the transaction at $2.47 per share. On Sep 12 ’24, another insider, Caplan Jay David, who serves as the President, Chief Product Off. of the company, sold 65,000 shares for $2.90 each. As a result, the insider received 188,474 and left with 30,484 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GUTS now has a Market Capitalization of 92349888 and an Enterprise Value of 64364108. For the stock, the TTM Price-to-Sale (P/S) ratio is 899.47 while its Price-to-Book (P/B) ratio in mrq is 1.79. Its current Enterprise Value per Revenue stands at 663.548 whereas that against EBITDA is -0.796.

Stock Price History:

Over the past 52 weeks, GUTS has reached a high of $14.50, while it has fallen to a 52-week low of $1.74. The 50-Day Moving Average of the stock is -18.21%, while the 200-Day Moving Average is calculated to be -54.63%.

Shares Statistics:

It appears that GUTS traded 316.66K shares on average per day over the past three months and 349600 shares per day over the past ten days. A total of 48.09M shares are outstanding, with a floating share count of 20.64M. Insiders hold about 57.09% of the company’s shares, while institutions hold 35.96% stake in the company. Shares short for GUTS as of 1732838400 were 2235330 with a Short Ratio of 7.06, compared to 1730332800 on 1913509. Therefore, it implies a Short% of Shares Outstanding of 2235330 and a Short% of Float of 9.1000006.

Most Popular